173 Performance of PERSARC as Prognostic Tool of Extremity Soft Tissue Sarcoma

Prognostic factors in soft tissue sarcoma

Prognostic Factors in Soft Tissue Sarcoma

Soft tissue sarcoma (STS) represents a heterogeneous group of mesenchymal malignant tumors with variable natural history. This term was first introduced to describe a circumscribed neoplasm consisting of malignant fat cell occurring principally in the trunk (Abernethy, 1817). Nowadays, more than 30 types of STS have been described, and many of these present innumerable subtypes. Despite this wi...

Prognostic factors in soft tissue sarcoma.

The ability to accurately define the prognosis for patients with soft tissue sarcoma is a continuing challenge. Classically, this has been accomplished through assessments of tumor size, histologic grade, location, and the presence of nodal or distant metastases. These criteria are the basis of the currently utilized American Joint Commission on Cancer (AJCC) staging system. However, several ot...

Multimodal Treatment for Soft Tissue Sarcoma of the Extremity

Radical surgery for colorectal cancer is undoubtedly necessary for stages I, II and III and must consider the removal of the intestinal segment and the relative afferent lymph node stations affected by the tumor. This surgical technique called Complete Mesocolon Excision seems to satisfy an optimal oncological quality. The aim of this retrospective preliminary study is to verify the actual poss...

Radiotherapy for Soft Tissue Sarcoma of the Proximal Lower Extremity

Soft-tissue sarcoma (STS) is a histopathologically diverse group of tumors accounting for approximately 10,000 new malignancies in the US each year. The proximal lower extremity is the most common site for STS, accounting for approximately one-third of all cases. Coordinated multimodality management in the form of surgery and radiation is often critical to local control, limb preservation, and ...